You are here:

tobramycin (Bramitob)


Following an abbreviated submission

tobramycin 300mg/4ml nebuliser solution (Bramitob) is accepted for use in NHS Scotland for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

This preparation offers an alternative to an existing nebuliser solution at a lower cost per dose.

Drug Details

Drug Name: tobramycin (Bramitob)
SMC Drug ID: 314/06
Manufacturer: Trinity-Chiesi Pharmaceuticals Ltd
Indication: Chronic pulmonary infection
BNF Category:
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 March 2009